CompletedNCT02192931
Creatine Compared With Placebo for Women Using Methamphetamine
About this title
Read the official source — NCT02192931Medication studyAges 18–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Salt Lake CitySee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateSeptember 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 65
- Sponsor
- Perry Renshaw
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT02192931
- Official title
Show the full official title
A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Salt Lake City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Perry Renshaw.
Did this study involve medication?
Yes. The study involved medication, including Creatine monohydrate.
Who was this study for?
Listed age limits: 18 years to 55 years.
